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The relationship between humans and the population of
indigenous microorganisms in their intestines (the gut
microbiota) is ancient and important. In a recent survey
exploring the relationship between mammals and their
microbiota it was found that individuals of the same species
were more likely to have a similar gut microbiota than
mammals of different species [1]. This observation held true
regardless of the geographic separation between the two
hosts. These results indicate that the composition of the
microbiota is dependent more on the identity of the host
than on geography and that host and microbiota have co-
evolved for their mutual benefit [1]. In essence, we are a
mosaic of millions of bacterial genomes that work in concert
with the one human genome.
The bulk of our bacterial colleagues are located in the
gastrointestinal tract, where the density of bacterial cells in
the colon has been estimated at 1011-1012 cells/ml [2]. This
close association is mutualistic in nature. The bacteria gain a
nutrient-rich environment and humans gain a vast genetic
repertoire of encoded physiological functions. Within this
repertoire are many genes whose products may help humans
adapt to changes in diet and lifestyle. With their short
generation times and abilities to swap DNA, the bacteria in
our gut adapt and evolve to meet the demands of their ever-
changing world, and because their world is our world they
serve to complement the human genome. The interactions
between host and microbiota determine the success of this
relationship. In a recent study published in the Proceedings
of the National Academy of Sciences, Samuel and colleagues
[3] demonstrate that short-chain fatty acids (SCFAs)
produced by the microbiota signal through the host
G-protein-coupled receptor (GPCR) Gpr41 and influence
weight gain and adiposity.
T Th he e   m mi ic cr ro ob bi io ot ta a   a an nd d   e en ne er rg gy y   h ha ar rv ve es st ti in ng g
We know from studies in germ-free (GF) mouse models that
the gut microbiota help to stimulate development of the
innate immune system. GF mice also tend to be smaller and
do not gain weight like conventionally raised mice. Studies
in humans have revealed a shift in the overall community
architecture of the gut microbiota in people who lose weight
by following either a low-fat or a low-carbohydrate diet. The
shift, as hosts lose adiposity, is marked by a reduction in the
ratio of Firmicutes to Bacteroidetes [4]. In a mouse model
under similar conditions, there are indications that the new
microbial composition is less efficient at harvesting energy
from nutrients [5]. These studies indicate a role for the gut
microbiota in our ability to extract energy from the foods we
eat and the ability to maintain a given weight. In fact, the
genomes of the microbiota contain many genes related to the
breakdown of complex polysaccharides that humans cannot
process on their own [6]. The fermentation of carbohydrates
by the gut microbiota results in the production of SCFAs.
In examining the relationship between SCFA production by
the microbiota and host signaling, Samuel and colleagues
examined the effects of microbiota-derived SCFAs on the
host GPCR Gpr41. Gpr41 is activated by the ligands propio-nate, butyrate, acetate and pentanoate, especially by the first
two. In GF mice, there was no apparent difference in adi-
posity or weight gain (while on a standard polysaccharide-
rich diet) between Gpr41-knockout GF mice and wild-type
GF mice. However, when Gpr41-knockout and wild-type GF
mice were colonized by the syntrophic partners Bacteroides
thetaiotaomicron  (Bt) and the archaeon Methanobrevi-
bacter smithii (Ms) (in which one organism lives off the
products of the other), Gpr41-knockout mice failed to gain as
much weight and adiposity as wild-type mice. This differ-
ence in the responses of Bt/Ms-colonized wild-type and
Bt/Ms-colonized Gpr41-knockout mice was also observed in
conventionally raised mice.
Further analysis indicated that serum levels of the anorexi-
genic (appetite-suppressing) hormones leptin and peptide
YY were lower in GF mice than in Bt/Ms-colonized mice, and
lower in Bt/Ms-colonized Gpr41-knockout mice than in
Bt/Ms-colonized wild-type mice. Leptin is derived from
adipose tissue and is involved in regulating many different
responses, including metabolic rate and eating behavior.
Peptide YY, among other activities, inhibits gut motility. As
they predicted, Samuel et al. [3] demonstrated enhanced gut
motility in Bt/Ms-colonized Gpr41-knockout mice compared
with Bt/Ms-colonized wild-type mice. Thus, one mechanism
by which Gpr41 and the gut microbiota appear to mediate
weight gain is to decrease food transit time in the small
intestine and thus increase time for absorption of SCFAs.
Interestingly, peptide YY levels were higher in colonized
Gpr41-knockout mice than in GF Gpr41-knockout mice,
suggesting that the gut microbiota may also induce peptide
YY expression via a mechanism independent of Gpr41.
Ever since the discovery of leptin and its effects on obesity,
attempts to develop drugs that target its function have failed.
GPCRs are an important class of drug targets; approximately
30% of pharmaceuticals in current use target this family of
receptors [7]. The results reported by Samuel et al. [3]
indicate that Gpr41 might be an attractive drug target for
countering obesity. However, the desired mechanisms of
such drugs are unclear, as increases in peptide YY levels also
increase satiety, and have been linked to decreases in human
obesity [8]. A more complete understanding of the down-
stream signaling and physiology controlled by Gpr41 will be
a prerequisite for such a drug-targeting strategy.
M Mi ic cr ro ob bi ia al l   m mo od du ul la at ti io on n   o of f   h ho os st t   s si ig gn na al li in ng g
In a broader context, modulation of host signaling pathways
is a common mechanism utilized by bacterial and viral
pathogens. Manipulation of host signaling machinery often
serves to promote the pathogen’s own agenda. For example,
Salmonella  species utilize a guanine-exchange factor to
induce membrane ruffling in host cells and promote their
own uptake, and then deploy a GTPase-activating protein to
downregulate membrane ruffling once they are inside the
cell. Other pathogens modulate host signaling to prevent
uptake by host cells, to block immune responses, or to direct
cellular machinery for other specific purposes to the benefit
of the pathogen [9]. Studies of bacterial and viral pathogens
have taught us fundamental lessons about the regulation of
signaling and normal physiology in eukaryotic cells. For
example, studies of the Rous sarcoma virus protein Src led to
the discovery of phosphorylation as a means of regulating
signaling [10]. In a recent study, the Vibrio parahaemo-
lyticus type III effector protein VopS was found to inhibit
host-cell Rho GTPases by covalently attaching AMP to them
[11]. This study of a bacterial pathogen provided the first
evidence for the role of ‘AMPylation’ in the regulation of
eukaryotic signaling.
Not all host-microbe conversations are private. Redundancy
and use of shared or common language are important
features of the signaling interactions between commensal
microorganisms and their animal hosts. Toll-like receptors
(TLRs) and Nod receptors provide major ‘trunk lines’
through which both pathogens and commensals interact
with the host. TLRs are sentinels of the immune system,
sensing the presence of many different types of microbial
products. Bacterial lipopolysaccharide (LPS) and peptido-
glycan are potent stimulators of the TLR system. Commensal
LPS and peptidoglycan help maintain homeostasis in the gut
epithelium and protect the gut mucosa from injury by
stimulating the production of the protective molecules IL-6,
TGF-β, KC-1 and heat-shock proteins [12]. Both pathogens
and commensals often target elements of the host innate
immune system in order to subvert host defenses. Commen-
sals have been shown to induce expression of an antimicrobial
protein, angiogenin-4, in order perhaps to reshape innate
immunity in the gut [13]. In fact, Gpr43, another receptor for
SCFAs, is known to be highly expressed on polymorpho-
nuclear leukocytes, and SCFAs are known to attract and
activate these cells [14]. The Gpr-microbiota signaling story
may be relevant to various inflammatory diseases of the gut;
strategies to interfere with Gpr signaling might prove useful
for treating these disorders (as well as obesity).
Monotypic associations of a microbial symbiont with its host
sometimes provide more dramatic examples of the effect of
microbial signaling on the host. In the squid/Vibrio fischeri
symbiosis, V. fischeri resides in the light organ of the host
and provides luminescence. V. fischeri stimulates the
expression of two squid genes: a putative LPS-binding
protein and a receptor for peptidoglycan. Both of these
proteins are required for the development of the squid’s light
organ [15]. In this example, symbiont signaling funda-
mentally alters the physiology of the host and induces the
formation of an environment conducive to the symbiont.
The elegant work of Samuel et al. [3] illuminates one path-
way through which the microbiota and host communicate.
However, the complex mix of SCFAs and other by-products
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potential host receptors, and the variation in expression of
both along the length of the gut and among different types of
host cells predict multiple levels of host-microbiota regula-
tion and response. In a recent study of obese and lean twins,
metagenomic analysis revealed the presence of a core
microbiome, defined by a set of ‘functional’ microbial genes
[16]. Further analysis of these data will undoubtedly lead to
an array of new potential signaling factors. With everyone
talking at once, the biggest challenge for us will be to learn
how to listen.
A Ac ck kn no ow wl le ed dg ge em me en nt ts s
JED is supported by NIH Postdoctoral Training Grant 2 T32 AI007328-21;
DAR is supported by an NIH Director’s Pioneer Award and a Doris Duke
Charitable Trust Distinguished Clinical Scientist Award.
R Re ef fe er re en nc ce es s
1. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS,
Schlegel ML, Tucker TA, Schrenzel MD, Knight R, Gordon JI: E Ev vo ol lu ut ti io on n
o of f   m ma am mm ma al ls s   a an nd d   t th he ei ir r   g gu ut t   m mi ic cr ro ob be es s. .   Science 2008, 3 32 20 0: :1647-1651.
2. Ley RE, Peterson DA, Gordon JI: E Ec co ol lo og gi ic ca al l   a an nd d   e ev vo ol lu ut ti io on na ar ry y   f fo or rc ce es s
s sh ha ap pi in ng g    m mi ic cr ro ob bi ia al l    d di iv ve er rs si it ty y    i in n    t th he e    h hu um ma an n    i in nt te es st ti in ne e. . Cell  2006,
1 12 24 4: :837-848.
3. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK,
Hammer RE, Williams SC, Crowley J, Yanagisawa M, Gordon JI:
E Ef ff fe ec ct ts s   o of f   t th he e   g gu ut t   m mi ic cr ro ob bi io ot ta a   o on n   h ho os st t   a ad di ip po os si it ty y   a ar re e   m mo od du ul la at te ed d   b by y   t th he e
s sh ho or rt t- -c ch ha ai in n    f fa at tt ty y- -a ac ci id d    b bi in nd di in ng g    G G    p pr ro ot te ei in n- -c co ou up pl le ed d    r re ec ce ep pt to or r, ,    G Gp pr r4 41 1. .
Proc Natl Acad Sci USA 2008, 1 10 05 5: :16767-16772.
4. Ley RE, Turnbaugh PJ, Klein S, Gordon JI: M Mi ic cr ro ob bi ia al l   e ec co ol lo og gy y: :   h hu um ma an n
g gu ut t   m mi ic cr ro ob be es s   a as ss so oc ci ia at te ed d   w wi it th h   o ob be es si it ty y. . Nature 2006, 4 44 44 4: :1022-1023.
5. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon
JI: A An n   o ob be es si it ty y- -a as ss so oc ci ia at te ed d   g gu ut t   m mi ic cr ro ob bi io om me e   w wi it th h   i in nc cr re ea as se ed d   c ca ap pa ac ci it ty y   f fo or r
e en ne er rg gy y   h ha ar rv ve es st t. . Nature 2006, 4 44 44 4: :1027-1031.
6. Hooper LV, Midtvedt T, Gordon JI: H Ho ow w   h ho os st t- -m mi ic cr ro ob bi ia al l   i in nt te er ra ac ct ti io on ns s
s sh ha ap pe e   t th he e   n nu ut tr ri ie en nt t   e en nv vi ir ro on nm me en nt t   o of f   t th he e   m ma am mm ma al li ia an n   i in nt te es st ti in ne e. .   Annu
Rev Nutr 2002, 2 22 2: :283-307.
7. Drews J: D Dr ru ug g   d di is sc co ov ve er ry y: :   a a   h hi is st to or ri ic ca al l   p pe er rs sp pe ec ct ti iv ve e. .   Science 2000, 2 28 87 7: :
1960-1964.
8. Gardiner JV, Jayasena CN, Bloom SR: G Gu ut t   h ho or rm mo on ne es s: :   a a   w we ei ig gh ht t   o of ff f
y yo ou ur r   m mi in nd d. . J Neuroendocrinol 2008, 2 20 0: :834-841.
9. Patel JC, Galan JE: M Ma an ni ip pu ul la at ti io on n   o of f   t th he e   h ho os st t   a ac ct ti in n   c cy yt to os sk ke el le et to on n   b by y   S Sa al l- -
m mo on ne el ll la a - -   a al ll l   i in n   t th he e   n na am me e   o of f   e en nt tr ry y. .   Curr Opin Microbiol 2005, 8 8: :10-15.
10. Butel JS: V Vi ir ra al l   c ca ar rc ci in no og ge en ne es si is s: :   r re ev ve el la at ti io on n   o of f   m mo ol le ec cu ul la ar r   m me ec ch ha an ni is sm ms s
a an nd d   e et ti io ol lo og gy y   o of f   h hu um ma an n   d di is se ea as se e. . Carcinogenesis 2000, 2 21 1: :405-426.
11. Yarbrough M, Li Y, Kinch LN, Grishin NV, Ball HL, Orth K: A AM MP Py yl la a- -
t ti io on n   o of f   R Rh ho o   G GT TP Pa as se es s   b by y   V Vi ib br ri io o   V Vo op pS S   d di is sr ru up pt ts s   e ef ff fe ec ct to or r   b bi in nd di in ng g   a an nd d
d do ow wn ns st tr re ea am m   s si ig gn na al li in ng g. .   Science 2009, 3 32 23 3: :269-272..
12. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R:
R Re ec co og gn ni it ti io on n   o of f   c co om mm me en ns sa al l   m mi ic cr ro of fl lo or ra a   b by y   t to ol ll l- -l li ik ke e   r re ec ce ep pt to or rs s   i is s   r re eq qu ui ir re ed d
f fo or r   i in nt te es st ti in na al l   h ho om me eo os st ta as si is s. .   Cell 2004, 1 11 18 8: :229-241.
13. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI: A An ng gi io og ge en ni in ns s: :   a a
n ne ew w   c cl la as ss s   o of f   m mi ic cr ro ob bi ic ci id da al l   p pr ro ot te ei in ns s   i in nv vo ol lv ve ed d   i in n   i in nn na at te e   i im mm mu un ni it ty y. .   Nat
Immunol 2003, 4 4: :269-273.
14. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME,
Brezillon S, Dupriez V, Vassart G, Van Damme J, Parmentier M,
Detheux M: F Fu un nc ct ti io on na al l    c ch ha ar ra ac ct te er ri iz za at ti io on n    o of f    h hu um ma an n    r re ec ce ep pt to or rs s    f fo or r
s sh ho or rt t   c ch ha ai in n   f fa at tt ty y   a ac ci id ds s   a an nd d   t th he ei ir r   r ro ol le e   i in n   p po ol ly ym mo or rp ph ho on nu uc cl le ea ar r   c ce el ll l   a ac ct ti i- -
v va at ti io on n. . J Biol Chem 2003, 2 27 78 8: :25481-25489.
15. Chun CK, Troll JV, Koroleva I, Brown B, Manzella L, Snir E,
Almabrazi H, Scheetz TE, Bonaldo Mde F, Casavant TL, Soares MB,
Ruby EG, McFall-Ngai MJ: E Ef ff fe ec ct ts s   o of f   c co ol lo on ni iz za at ti io on n, ,   l lu um mi in ne es sc ce en nc ce e, ,   a an nd d
a au ut to oi in nd du uc ce er r   o on n   h ho os st t   t tr ra an ns sc cr ri ip pt ti io on n   d du ur ri in ng g   d de ev ve el lo op pm me en nt t   o of f   t th he e   s sq qu ui id d- -
v vi ib br ri io o   a as ss so oc ci ia at ti io on n. . Proc Natl Acad Sci USA 2008, 1 10 05 5: :11323-11328.
16. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A,
Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henris-
sat B, Heath AC, Knight R, Gordon JI: A A   c co or re e   g gu ut t   m mi ic cr ro ob bi io om me e   i in n
o ob be es se e   a an nd d   l le ea an n   t tw wi in ns s. . Nature 2008, doi:10.1038/nature07540.
http://genomebiology.com/2009/10/1/203 Genome B Bi io ol lo og gy y 2009, Volume 10, Issue 1, Article 203 Dinalo and Relman 203.3
Genome B Bi io ol lo og gy y   2009, 1 10 0: :203